Children administered with gene therapy can now see shapes, find toys, and read and write after world-first treatment ...
Medics in the UK have become the first in the world to successfully administer a pioneering gene therapy that preserves sight in young children with an extremely rare genetic condition that usually ...
A groundbreaking gene therapy has restored sight in four young children born with severe blindness due to a rare genetic deficiency. Scientists at UCL and Moorfields Eye Hospital successfully injected ...
At the Envision Summit 2025 in San Juan, Puerto Rico, Sharon Fekrat, MD, FACS, FASRS talked about multi-modal retinal and ...
D Molecular Therapeutics is undervalued, with its lead candidate 4D-150 showing potential. Click here to find out why I rate ...
First patient dosed in the pediatric cohort of the Phase 1/2 trial of OPGx-LCA5; initial data on the cohort anticipated by Q3 2025New 12-month ...
Company shares preliminary results from Phase 1/2 clinical trial for patients with advanced Retinitis Pigmentosa (RP)NEW YORK, Feb. 18, 2025 ...
Cataracts, dry eyes, glaucoma and other eye problems become more common with age. But these can be treated — and sometimes ...
Lutein is more than an eye-protecting nutrient. New research reveals its role in brain health and disease prevention. Learn ...
However, the study provides limited new insights into the relationship between retinal lamination defects and overall retinal function. Neural lamination is a common feature of the central nervous ...
In today’s fast-paced world, eye health often takes a back seat as we navigate through our daily routines filled with screens and artificial lighting. An alarming increase in eye strain, fatigue, and ...
The authors concluded, “Tyrosine kinase inhibitor achieved durable disease control in epidermal growth factor receptor mutation-positive non–small-cell lung carcinoma in patients with choroidal ...